PORTFOLIO COMPANION DIAGNOSTICS ENABLING TECHNOLOGIES RESOURCES OUR CULTURE About Contact Careers Search Genetics Oncology MolecularDx Controls SPOTLIGHT Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis CFTR testing kit with streamlined workflow delivers reliable results in less than five hours LEARN MORE SPOTLIGHT Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control Asuragen, Inc has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic. The Latest from Asuragen Looking Beyond Copy Number: Broad SMN1 and SMN2 profiling in under four hours with the AmplideX® PCR/CE SMN1/2 Plus Kit PRESS RELEASE Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry PRESS RELEASE Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control PRESS RELEASE Asuragen Partners with Wave Life Sciences to Develop Companion Diagnostics for Huntington’s Disease 2150 Woodward St., Suite 100 Austin, TX 78744 USA PORTFOLIO COMPANION DIAGNOSTICS ENABLING TECHNOLOGIES RESOURCES COMMUNITY About Contact Careers © Copyright 2021 ASURAGEN, INC. An Equal Opportunity Employer. All Rights Reserved. Privacy Policy Website Terms of Use Financial Conflict of Interest Policy

PORTFOLIO COMPANION DIAGNOSTICS ENABLING TECHNOLOGIES RESOURCES OUR CULTURE About Contact Careers Search BUSINESS DEVELOPMENT HomeAboutBusiness Development We are actively engaged in and seeking complementary discovery collaborations, joint development projects and licensing arrangements as well as the development and commercialization of specialized custom OEM products. Our goal is to accelerate drug discovery, diagnostic test development, and therapeutic applications within the marketplace. Asuragen has commercial expertise, capabilities, and resources to develop novel technologies, innovative products, and services. We bring a collegial collaborative approach to all business relationships and partnerships. Please contact: Corporate Business Development Asuragen, Inc. 2150 Woodward St., Suite 100 Austin, Texas, 78744 USA Phone: 512.681.5200 Email: corporatebd@asuragen.com About About Leadership Team Board of Directors Culture and Heritage Press Releases Upcoming Events Business Development 2150 Woodward St., Suite 100 Austin, TX 78744 USA PORTFOLIO COMPANION DIAGNOSTICS ENABLING TECHNOLOGIES RESOURCES COMMUNITY About Contact Careers © Copyright 2021 ASURAGEN, INC. An Equal Opportunity Employer. All Rights Reserved. Privacy Policy Website Terms of Use Financial Conflict of Interest Policy